For additional information, please contact Mr. John Bentivoglio Sr VP Event Cardio Group Inc. Email: johnb@eventcardiogroup.com Direct U.S. Line: 561-271-7157 or Direct Canadian Line: 289-407-4377 -Or- Nicholas Bozza President Event Cardio Group Inc. Email: nickb@eventcardiogroup.com Canadian Direct Canadian Line: (905) 650 4022
Jim Carson leads the patent and trademark areas of Blaney McMurtry's Intellectual Property Group With over 25 years’ experience, Mr. Carson’s practice covers the full range of intellectual property law: the identification and protection of trade-marks, domain names, industrial designs, copyright and inventions in Canada, the United States and internationally; the review and preparation of technology transfer agreements and intellectual property licensing, confidentiality and distribution agreements; performing due diligence in connection with the intellectual property aspects of business acquisitions; and conducting Intellectual Property litigation. Mr. Carson is both a registered Patent Agent and registered Trade-Mark Agent in Canada, a registered U.S. Patent and Trademark agent and a member of the Intellectual Property Institute of Canada, the Intellectual Property Section of the Canadian Bar Association and the International Trademark Association (“INTA”).
A Google search of the new phone number listed on yesterday's 8-K shows there is a connection to Event Cardio Group (a start-up medical device/software/telemedicine company based in Canada). I am assuming the RM will likely be done with this company.....
It would appear there is now a pretty strong possibility that Event Cardio Group (ECGI) is the RM target for the SUIP shell. John Bentivoglio's purchase of an equity/control stake in SUIP, and the information contained in Bentivoglio's United States LinkedIn profile page, would seem to point in that direction.
I'm not entirely sure at the moment what the management of the RM would look like, since the management section of ECGI's website and Bentivoglio's LinkedIn information currently conflict with each other.....
John Bentivoglio CEO and President, ECG Inc. United States|Medical Devices
CEO and President Event Cardio Group Inc. September 2012 – Present (1 year 11 months)
John Bentivoglio, is focused on his newest role as President, CEO and Main Principal of Event Cardio Group. For John, being the Main Principle of a Public Company, comes after many successful years of assisting, and being a partner.
CardioNow
Played a key role in development of “NowCardio”, a modern cardio-monitoring product, over the past two years. Actively sought out fund raising, while developing strategies for entering the public market.